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Charcot-Marie-Tooth disease type 4C (CMT4C) is a childhood-onset demyelinating form of hereditary motor and
sensory neuropathy associated with an early-onset scoliosis and a distinct Schwann cell pathology. CMT4C is inherited
as an autosomal recessive trait and has been mapped to a 13-cM linkage interval on chromosome 5q23-q33.
By homozygosity mapping and allele-sharing analysis, we reﬁned the CMT4C locus to a suggestive critical region
of 1.7 Mb. We subsequently identiﬁed mutations in an uncharacterized transcript, KIAA1985, in 12 families with
autosomal recessive neuropathy. We observed eight distinct protein-truncating mutations and three nonconservative
missense mutations affecting amino acids conserved through evolution. In all families, we identiﬁed a mutation on
each disease allele, either in the homozygous or in the compound heterozygous state. The CMT4C gene is strongly
expressed in neural tissues, including peripheral nerve tissue. The translated protein deﬁnes a new protein family
of unknown function with putative orthologues in vertebrates. Comparative sequence alignments indicate that
members of this protein family contain multiple SH3 and TPR domains that are likely involved in the formation
of protein complexes.
Introduction
Charcot-Marie-Tooth disease (CMT) comprises a group
of clinically and genetically heterogeneous hereditarymo-
tor and sensory neuropathies (HMSNs). With an overall
population prevalence of 1 in 2,500, CMT constitutes the
most common inherited neuromuscular disorder (Skre
1974). The clinical picture includes progressive distal
muscle weakness and atrophy, foot deformities, and
distal sensory loss. Two major types have been dis-
cerned by combined clinical, electrophysiological, and
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nerve biopsy studies (Dyck et al. 1993). The demye-
linating form (CMT1 or HMSN I [summarized in MIM
118200 for CMT1B]) is characterized by reduced nerve-
conduction velocities (NCVs) with values !38 m/s for the
motor median nerve, segmental demyelination and re-
myelination, and onion bulb formation in nerve biopsies.
These changes differentiate CMT1 from the axonal type
(CMT2 or HMSN II [summarized in MIM 118210 for
CMT2A]), in which NCVs are near normal and nerve
pathology shows signs of axonal degeneration. Both
forms are usually inherited as an autosomal dominant
trait, but autosomal recessive and X-linked inheritance
also occurs. In recent years, considerable advances have
been made in understanding the molecular genetics of
CMT neuropathies. (Mutations of genes that cause CMT
are listed in the Inherited Peripheral Neuropathies Mu-
tation database.)
Autosomal recessive CMT neuropathies are, in gen-
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eral, much less common than the dominant forms. Skre
(1974) estimated the frequency of autosomal recessive
CMT to be 1.4 per 100,000 in western Norway. How-
ever, in communities with a high prevalence of consan-
guineous marriages, autosomal recessive inheritance is
likely to account for 30%–50% of all forms of CMT
and may even be the most common form (European
CMT-Consortium–ENMC 1999). The clinical presen-
tation is similar to dominant CMT, but it is usually more
severe and has an earlier onset age (Harding and Tho-
mas 1980; Thomas 2000). The distinction in demyelin-
ating and axonal forms is also valid for the recessive
CMTs, with the demyelinating forms named “CMT4”
(summarized in MIM 214400 for CMT4A) and the ax-
onal types designated “ARCMT2” (MIM 605588 for
CMT2B1; MIM 605589 for CMT2B2). Autosomal re-
cessive CMT is genetically heterogeneous, with 11
chromosomal loci involved. One form of recessive de-
myelinating CMT, CMT4C (MIM 601596), was
mapped to chromosome 5q23-q33 in two Algerian in-
bred kindreds (LeGuern et al. 1996). Additional families
compatible with linkage to CMT4C were reported from
the Mediterranean basin and in a cohort of Dutch fami-
lies (Gabree¨ls-Festen et al. 1999; Guilbot et al. 1999;
Nelis et al. 2001). It has been suggested that CMT4C
is associated with a peculiar peripheral-nerve pathology
characterized by a combination of extended formation
of Schwann cell processes and onion bulbs consisting
only of basal membranes. Clinically, CMT4C is com-
plicated by an early-onset, severe scoliosis that contrasts
with the relatively mild peripheral neuropathy symp-
toms (Kessali et al. 1997; Gabree¨ls-Festen et al. 1999).
Since the ﬁrst recognition of theCMT4C locus in 1996,
seven genes responsible for recessive CMT subtypes have
been identiﬁed (Warner et al. 1998; Bolino et al. 2000;
Kalaydjieva et al. 2000; Boerkoel et al. 2001; Guilbot et
al. 2001b; Baxter et al. 2002; Cuesta et al. 2002; De
Sandre-Giovannoli et al. 2002; Azzedine et al. 2003; Sen-
derek et al. 2003), but the CMT4C gene has remained
unknown. In this study, we report the ﬁne mapping of
the CMT4C locus and the identiﬁcation of a novel gene
that, when mutated, causes CMT4C.
Subjects and Methods
Patients
We obtained family data and blood samples for iso-
lation of genomic DNA, after receiving informed consent
from the patients with CMT and their healthy relatives,
according to the Declaration of Helsinki and protocols
approved by the review boards for medical ethics at the
different institutions involved in this study. A series of
14 families with CMT (including 21 affected individuals)
was available for the initial search for the CMT4C gene.
Diagnostic criteria were (i) sensorimotor neuropathywith
onset in the 1st or 2nd decade, (ii) absence of clinical
symptoms and neurophysiological signs in the parents,
and (iii) parental consanguinity or at least one other
affected sibling (European CMT-Consortium–ENMC
1999). Most of the patients were diagnosed with a de-
myelinating neuropathy. After revealing the identity of
the CMT4C gene, we screened a set of 55 families with
recessive CMT (including 72 patients) for compatibility
with linkage to the CMT4C region. Those families com-
patible with linkage underwent mutation analysis. We
also sequenced the novel CMT4C gene in 21 patients
whose DNAs were received for routine diagnostic testing
for demyelinating CMT. These patients were mainly sin-
gle affected children whose parents were reported to be
nonconsanguineous and healthy. Six of the patients had
severe, early-onset scoliosis.
Reﬁnement of the CMT4C Locus
Haplotype analysis at theCMT4C locuswas performed
with STR polymorphism markers D5S658, D5S2011,
D5S1360, D5S2090, D5S413, D5S2015, D5S636, and
D5S673 (Genome Database and November 2002 release
of the public genome assembly at the University of Cali-
fornia–Santa Cruz [UCSC]). For ﬁne mapping and allele-
sharing analysis, 10 additional STRs were retrieved from
public databases, and 15 new repeat polymorphismswere
identiﬁed by using the Repeat-Masker program on ge-
nomic DNA from the critical interval. Primers for PCR
ampliﬁcation of known STRs are reported in the Genome
Database, and primers for new STRs were designed by
the Primer3 program (table A [online only]). Sense prim-
ers were labeled with FAM ﬂuorophores (MWG Biotech)
for analysis on an ABI 377 DNA sequencer (Applied Bios-
ystems). Data on 12 SNPs from the minimal candidate
interval were retrieved from the NCBI dbSNP database
and ABI SNP genotyping repository (table B [online
only]). Sequences were PCR ampliﬁed and assayed by
DNA sequencing with ABI dye terminator technology
(Applied Biosystems) for electrophoresis on an ABI 310
genetic analyzer (Applied Biosystems).
Candidate Gene Analysis
For selection of candidate genes, we used the Novem-
ber 2002 freeze of the UCSC human genome assembly.
The UCSC map provided known proteins and genes (as
curated by Swiss-Prot and the NCBI RefSeq project),
aligned mRNAs, ESTs, Unigene clusters, Ensembl gene
builds, Genscan and FGENESH gene predictions, and
alignments of other genomes by similarity. Selection of
positional candidate genes and anonymous transcripts
was performed on the basis of neural expression, espe-
cially in spinal cord and peripheral nerve. We queried
public data repositories for EST matches and SAGE (se-
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Figure 1 Homozygosity mapping in CMT4C-affected families
(CMT-133 and M149) with chromosome 5q32 markers. A subset of
markers used in this study is given in cen-qter orientation. The physical
map positions are according to the UCSC November 2002 freeze. The
informativity of each marker is shown as a calculated heterozygosity
rate for microsatellite markers (“D5S” locus numbers and plain nu-
merals) and as a minor allele frequency for SNPs (“rs” numbers).
Values determined in the Turkish population are marked by an asterisk
(*). Haplotypes are shown for affected and healthy offspring. Paternal
haplotypes are shown at left; maternal haplotypes are at right. Infor-
mative alleles in the affected individuals are underlined. Regions of
homozygosity and shared haplotypes are boxed. The recombination
events suggested from regions of homozygosity in patient M149.V.1
support a 5.6-Mb critical interval ﬂanked by markers D5S1360 and
D5S636 (single arrowheads). Further reﬁnement was inferred through
identical haplotypes shared by patients CMT-133.IV.2 and M149.V.1
between markers 91948 and rs2276982 (double arrowheads). This
narrowed the critical genetic region to a suggestive interval of 1.7Mb.
rial analysis of gene expression) tags and evaluatedmicro-
array data on the temporal expression pattern of genes
during sciatic nerve myelination (Verheijen et al. 2003).
To test for expression of candidate genes by RT-PCR,
total human sciatic nerve and spinal cord RNAs were
extracted using the RNeasy kit (Qiagen) and were reverse
transcribed by oligo-dT primers and AMV reverse tran-
scriptase (Promega). RT-PCR-products were generated
using gene-speciﬁc exonic primer sets.
Five transcripts (SP329/FLJ13962 [GenBank acces-
sion numbers AF177339 and AK024024], KIAA1985
[GenBank accession numbers AB075865, BQ421935,
BQ213149, W86370, BM552239, BE026883, and
BE302610; HUGE Protein Database], KIAA0843
[GenBank accession number AB020650; HUGE Protein
Database], FLJ23713 [GenBank accession number
AK074293], and CSNK1A1 [GenBank accession number
NM_001892]) were screened for mutations. Primers
ﬂanking exons were used to amplify genomic DNA, and
products were subjected to DNA sequencing on ABI 310
or 3730 DNA analyzers (Applied Biosystems) (for
KIAA1985 primers, see table C [online only]). Sequence
variants were identiﬁed by visual inspection of electro-
pherograms. The DNAs of parents and siblings were se-
quenced to test for segregation ofmutations.Control sam-
ples were screened by restriction enzyme digestion or by
WAVE denaturing high-performance liquid chroma-
tography (Transgenomic).
Expression Study
A 535-bp cDNA fragment encompassing KIAA1985
exons 15–17 was ampliﬁed by RT-PCR and was cloned
in the pCRII-TOPO vector (Invitrogen). A 693-bp cDNA
fragment corresponding to exons 1–6 was obtained by
KpnI and BsmI digestion from the IMAGE cDNA clone
6048901 obtained through RZPDDeutschesRessourcen-
zentrum fu¨r Genomforschung. Inserts were gel puriﬁed,
were [32P]-labeled with a Multiprime kit (Amersham Bio-
sciences), and were hybridized to a human adult multiple-
tissue northern blot (BD Bioscience). Hybridization was
performed for 1 h at 68C with Express Hyb solution
(BD Bioscience). Membranes were washed for 3# 30
min in , 0.05% SDS, at room temperature, fol-2# SSC
lowed by min washes in , 0.1% SDS3# 30 0.1# SSC
at 50C. Filters were exposed to autoradiography ﬁlm for
24–36 h at 70C. Human b-actin probes were used for
control hybridizations.
For RT-PCR, total RNA and cDNA from human adult
sciatic nerve, spinal cord, brain, and skeletal musclewere
prepared as described above. Overlapping RT-PCR frag-
ments covering the KIAA1985 cDNA were sequenced
(table D [online only]). Expression levels were assessed
by using b2-microglobulin–speciﬁc primers in control re-
actions. For the expression analysis of the mouse ortho-
Senderek et al.: Identiﬁcation of the CMT4C Gene 1109
Figure 2 Transcript map of the CMT4C region on 5q32, genomic organization of the CMT4C gene, and alternative splicing of its transcripts.
A, Partial physical and transcript map of the 1.7-Mb CMT4C linkage region delimited by the centromeric marker 91948 and telomeric marker
rs2276982. Known genes (shown in bold text) and predicted genes (shown in plain text) are indicated by arrows in the direction of transcription.
B, Genomic structure of the CMT4C gene (KIAA1985). The gene covers 62 kb of genomic sequence and consists of18 variably spliced exons.
Exons are indicated by vertical hatches and are numbered. Empty bars represent alternatively spliced sequences. The sizes of introns are shown
relative to each other. C, Alternative splice products of KIAA1985. The transcript encoding the putative full-length protein is given above the
products. Coding regions of exons are drawn to scale. Use of exon 6s (instead of 6), presence of exon 8A, and retention of intron 10 predict shorter
translation products. An asterisk (*) indicates predicted translation-initiation site; a double asterisk (**) indicates predicted translation-termination
signal.
logue D430044G18Rik (GenBank accession numbers
AK052534, BC037000, BI414954, and NM_172628),
we ampliﬁed exons 4–11 in cDNA from brain, ventral
horn (VH) of spinal cord, and dorsal root ganglia (DRG)
of E13 mouse embryos, and we cloned the products in
the pCRII-TOPO vector with the TOPO TA Cloning kit
(Invitrogen). After one-shot electroporation, 20 colonies
were selected for each tissue, and the inserts were
sequenced.
Results
Reﬁnement of the CMT4C Interval
The initial 13-cM CMT4C linkage interval between
markers D5S658 andD5S673 (LeGuern et al. 1996) could
not be reﬁned in subsequent studies (Gabree¨ls-Festen et
al. 1999; Guilbot et al. 1999, 2001a). To establish com-
patibility with linkage to CMT4C in further kindreds, we
selected 14 families with CMTwithmultiple affected chil-
dren or parental consanguinity. Haplotype analysis was
compatible with linkage to CMT4C in ﬁve families: two
German nonconsanguineous multiplex families (M983
and M1494) and three consanguineous Turkish nuclear
families (CMT-133, M149, and M2045). Family M149
yielded recombination events by homozygosity by de-
scent, reducing the CMT4C critical region, within sug-
gestive borders, to 5.6 cMbetweenmarkersD5S1360 and
D5S636 (ﬁg. 1). Genotyping of additional STRs from the
reduced region conﬁrmed homozygosity at the CMT4C
locus in all three Turkish families. Moreover, in families
CMT-133 and M149, we observed a shared disease hap-
lotype between STRs 91948 and 11382, suggesting fur-
ther reﬁnement of the CMT4C region to 1.8 Mb. Geno-
typing of SNPs from this interval showed an ancestral
recombination event, under the assumption of a common
haplotype, for rs2276982 and the gene (ﬁg. 1). The shared
20-marker haplotype spanned a 1.7-Mb interval and con-
tained rare alleles for STRs 116312A, D5S413, 12613,
8681, and 8545 and for SNP rs3733847. This haplotype
was not detected in 23 Turkish control individuals, and
both affected individuals were heterozygous for STR
markers at other recessive CMT loci (data not shown).
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Table 1
Clinical, Electrophysiologic, and Morphological Data in CMT4C
FAMILY
AND PATIENT SEX
ETHNIC
ORIGIN MUTATIONa CONSANGUINITY
AGE AT
WALKING
(mo)
AGE AT
DIAGNOSIS
(YEARS)
AGE AT LAST
EXAMINATION
(YEARS)
DISTAL
WEAKNESSb
DISTAL
MUSCLE
ATROPHYb
INVOLVEMENT
OF PROXIMAL
MUSCLESc
FOOT
DEFORMITYd
CMT-133:
CMT-133.IV.2 M Turkish R529Q (hom)  30 Infancy 8    (legs) 
M149:
M149.V.1 M Turkish R529Q (hom)  11 7 8.5    
M983:
M983.II.3 M German Y943X (pat)  18 11 17    
M983.II.7 F R954X (mat) 19 5 26    (legs) 
M983.II.8 F 18 7 11    
M2045:
M2045.IV.2 F Turkish R9fsX13 (hom)  12 8 8.5    
CMT-189:
CMT-189.V.1 F Italian IVS5-2ArG (hom)  14 Infancy 45    
CMT-189.V.4 M 16 Infancy 39    (legs) 
CMT-189.V.5 F 24 Infancy 15    
CMT-189.V.6 M 15 4–5 30    
PN-1289:
PN-1289.1 F Iranian S831fs (hom)  118 Infancy 17    
CMT-219:
CMT-219.1 F Turkish G583fs (hom)  11 29    
CMT-225:
CMT-225.1 M Turkish P1114fs (hom)  12 25   
CMT-234:
CMT-234.1 M Turkish E657K (hom)  Delayed 2–3 26    
CMT-235:
CMT-235.1 F Turkish G583fs (hom)  18 Infancy 14    
AC70:
AC70.II.1 F Greek R954X (pat) Q1201X (mat)  21 Infancy 8.5    
H1351:
H1351.II.2 M German R658C (pat)  Delayed 12 33    
H1351.II.4 F R954X (mat) 27    
a hom p homozygous alleles; pat p paternal allele; mat p maternal allele.
b  p not affected;  p mild in the lower extremities;  p marked in the lower extremities;  p also affecting the hands and forearms.
c  p not affected;  p mild;  p severe.
d  p no deformity;  p pes cavus and hammer toes;  p clubfoot deformity;  p surgery required.
e  p decreased sensibility;  p absent sensibility.
f  p none;  p mild;  p severe;  p surgery required.
g Upper/lower extremities;  p normal; () p decreased;  p absent.
h Normal values: motor-median and ulnar nerve 145 m/s; motor-tibial and peroneal nerve 140 m/s; sensory median nerve 145 m/s; sural nerve 140 m/s. NR p not recordable.
i Light microscopy indicated a demyelinating neuropathy in all investigated cases. Electron microscopy (EM) ﬁndings: BLOB p basal lamina onion bulbs; SC p Schwann cell;  p not
observed;  p present;  p prominent ﬁnding. ND p no biopsy done.
Mutation Analysis
Eight known genes and eight anonymous transcripts
mapped within the 1.7-Mb CMT4C region (represented
by GenBank human genomic contig NT_006859), none
of which was an apparent candidate gene for a peripheral
neuropathy (ﬁg. 2). Experimental and in silico expression
studies did not allow a clear categorization of positional
candidates by likelihood of being the disease gene. We
performed mutation analysis on DNAs of the affected
individuals from the ﬁve putative families with CMT4C.
No pathogenic mutations were found in CSNK1A1,
SP329/FLJ13962, KIAA0843, and FLJ23713 (data not
shown). However, in KIAA1985, sequence variations
were detected in four of the ﬁve families (CMT-133,
M149, M983, and M2045) predicted to result in three
truncating changes and one missense mutation (tables 1
and 2; ﬁg. 3). All affected individuals were identiﬁed
with mutations on both alleles; the parents carried these
mutations in the heterozygous state, whereas unaffected
siblings also carried one mutation or were homozygous
for the wild-type alleles. Consistent with the common
ﬂanking haplotype in families CMT-133 and M149, we
found a shared seven-marker intragenic SNP haplotype
(table E [online only]) and the same c.1586GrA tran-
sition causing an R529Q exchange. Among 160 Turkish
control subjects, we found one heterozygous individual
for the c.1586GrA mutation. That person also shared
the ﬂanking and intragenic haplotype found in families
CMT-133 and M149. The c.1586GrA transition was
not found in the western European control population
(600 chromosomes). The mutations in families M983
and M2045 were absent from 120 control chromosomes
matched for ethnic background.
When we screened a cohort of 55 families with auto-
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NCV (m/s)h
Motor NCV Sensory NCV NERVE BIOPSY (EM)i
WALKING
AIDS
(SINCE AGE
IN YEARS)
DISTAL
SENSORY
LOSSe
SCOLIOSIS
(AGE AT
ONSET
IN YEARS)f REFLEXESg Median Ulnar Peroneal Tibial Median Sural BLOB
Branching
of SC
OTHER
(AGE AT ONSET IN YEARS)
   ()/ 27 37 24 NR  
   / 24.1 25.7 23.4 29.9 32.2 ND
   (11) / 13.9 9.5 NR  
Peroneal braces   ()/ 25 20.9 13.8 6.7 37.8 NR  
   / 38 24 ND
   ()/() 33 28 30  
   (infancy) / 21.6 23.7 NR ND Hypoacusis
   / 19.5 17.6 NR NR   Deafness
Chairbound (15)   (7) / ND Respiratory insufﬁciency (30)
   / 21.1 26.9 NR ND Hypoventilation (28); hypoacusis
   (12) / 32 38 27 NR ND Congenital nystagmus
Chairbound  / 13 12 ND Diabetes mellitus
  / 4 ND Three affected brothers
Walks with aid  / 12 ND Nystagmus; palpable great
auricular nerve
   / 26 21 34 NR   Asymmetry of pareses
Chairbound (7.5)   (4) / 27 16 16 NR   CPAP treatment required at night
   ()/ 28 NR 30 39 NR ND
   ()/ 37 12 ND
somal recessive CMT by using closely linked, highly in-
formative markers 91948, 116312A, and 8681, we dis-
covered 15 families compatible with CMT4C.KIAA1985
sequencing revealed homozygous mutations in six fami-
lies, CMT-189, CMT-219, CMT-225, CMT-234, CMT-
235, and PN-1289 (tables 1 and 2; ﬁg. 3). We also
screened 21 patients with early-onset demyelinating neu-
ropathy, who requested DNA diagnosis for CMT. In two
patients, one with an affected sibling (family H1351)
and another with sporadic disease (patient AC70.II.1),
we found compound heterozygous sequence variations
in KIAA1985 (tables 1 and 2). In the case of missense
mutations, 220 control chromosomes from a similar
ethnic background were analyzed and found to be neg-
ative for the mutations. Corresponding segregation of
mutations was found in every family.
Expression Analysis and Genomic Organization
On human adult multiple-tissue northern blots, we
found expression of KIAA1985 to be strong in brain and
spinal cord and to be very weak in striated muscle. Two
bands at ∼7.5 kb and ∼4.5 kb were observed with 5′ and
3′ KIAA1985 probes. RT-PCR experiments revealed equal
levels of expression in spinal cord and sciatic nerve (ﬁg.
4). The reported KIAA1985 mRNA corresponded to the
size of the 7.5-kb band on the northern blot. An alter-
native polyadenylation signal was predicted by the Poly-
adq algorithm at ∼4.5 kb and may give rise to the smaller
band. We conﬁrmed the KIAA1985 mRNA sequence by
alignment with human EST sequences by querying the
NCBI dbEST database and by RT-PCR ampliﬁcation on
mRNA from sciatic nerve, brain, and spinal cord (ﬁg.
A [online only]). The putative ATG translation-initiation
codon is surrounded by an incomplete Kozak consensus
sequence (ACACACATGG) (Kozak 1989) and is pre-
ceded by an inframe stop codon 15 bp upstream. The
longest continuous ORF (GenBank accession number
AY341075) predicts a protein of 1,288 amino acids,with
a calculated molecular mass of 144.7 kDa (ﬁg. B [online
only]). Sequence alignments of the conﬁrmedKIAA1985
cDNA with genomic sequences on 5q32 were performed
with the BLAT tool implemented on the UCSC Web site.
The KIAA1985 gene is ﬂanked by the centromeric
marker D5S413 and the novel telomeric marker 91940.
The gene is transcribed from telomere to centromere and
spans 62 kb of genomic sequence. We identiﬁed a total
of 18 exons; the longest putative ORF is encoded by a
17-exon transcript (ﬁg. 2). All exon-intron boundaries
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Table 2
Mutations Detected in Patients with CMT4C
Exon/Intron Nucleotide Change Effect on Coding Sequence Families with CMT4Ca Ethnic Origin
1 c.26delG R9fsX13 M2045 (hom) Turkish
IVS5 IVS5-2ArG Exon skipping supposed CMT-189 (hom) Italian
11 c.1586GrAb R529Qb CMT-133c (hom), M149c (hom) Turkish
11 c.1747_1748delAG G583fsX586 CMT-235c (hom), CMT-219c (hom) Turkish
11 c.1969GrA E657K CMT-234 (hom) Turkish
11 c.1972CrT R658C H1351 (het) German
11 c.2491_2492delAG S831fsX839 PN-1289 (hom) Iranian
11 c.2829TrG Y943X M983 (het) German
11 c.2860CrT R954X M983c (het), H1351c (het), AC70c (het) German, Greek
15 c.3341delC P1114fsX1115 CMT-225 (hom) Turkish
16 c.3601CrT Q1201X AC70 (het) Greek
a hom p homozygous; het p heterozygous.
b The R529Q mutation was also found in 1 of 320 Turkish control chromosomes. The same ﬂanking and intragenic poly-
morphisms as those in CMT-133 and M149 were observed.
c Disease chromosomes carried the same ﬂanking and intragenic polymorphisms.
followed the canonical GT/AG rule. The size of exons
had a range of 42–1,695 bp, and the length of introns
was 0.1–14 kb.
There is evidence that the KIAA1985 gene is alter-
natively spliced. The skipping of the last 58 bp of exon
6 (exon 6s), the insertion of a 130-bp exon between exons
8 and 9 (exon 8A), and the retention of the 122-bp in-
tron 10 were found in ESTs and in RT-PCR–ampliﬁed
transcripts from sciatic nerve, spinal cord, and brain
(ﬁgs. 2 and 4). These variants may account for the slight
smearing of the bands in the northern blot but do not
yield additional signals, since they alter the size of the
transcript by only, at maximum, 5% (ﬁg. 4). The alter-
native exons all exhibited consensus donor and acceptor
splice sites. Alternatively spliced transcripts, if trans-
lated, would result in a frameshift generating a stop co-
don with consecutive extensive truncation of the protein.
RT-PCR analysis revealed the dominant expression of
alternative transcripts, compared with the intact form in
brain and spinal cord. Peripheral nerve, however, mainly
expressed the transcript encoding the full-length protein
(ﬁg. 4).
Analysis of 20 cDNA clones from brain, VH, and
DRG of the mouse orthologue D430044G18Rik iden-
tiﬁed a deletion of the ﬁrst 16 bp of exon 6 in one clone
from brain and one from DRG. A longer version of exon
6 (retaining 154 bp before exon 6) was discovered in
cDNA from brain and VH. In 4 of the 20 DRG clones,
exon 9 was deleted, and one DRG clone showed a de-
letion of the ﬁrst 68 bp of exon 8. By genomic alignment,
all splice junctions followed the canonical GT/AG rule.
All alternatively spliced transcripts were predicted to shift
the reading frame, resulting in severely truncated forms
of the D430044G18Rik protein.
Characterization of the Encoded Protein
No signiﬁcant sequence similarity to known human
cDNA or protein sequences was found with the
KIAA1985 protein. SMART and ScanProsite analyses on
the human and mouse orthologues indicated the presence
of two N-terminal SH3 (Src homology 3) domains (Pfam
database accession number PF00018) and 10 TPR (tetra-
tricopeptide repeat) motifs (Pfam database accession
number PF00515) arranged in tandem arrays (ﬁg. 5).
ScanProsite predicted a putative N-terminal myristylation
signal, two bipartite nuclear localization signals, a peroxi-
somal targeting signal, two sites for glycosylation and
sulfatation, and multiple phosphorylation sites. The ob-
served splice variants, if translated into protein, would
encode SH3 domain–only polypeptides. Conservedortho-
logueswere detected by alignment ofKIAA1985withEST
and genomic sequences of various vertebrates. There was
a strong sequence conservation for KIAA1985 during
evolution, with 81% amino acid identity of human
KIAA1985 with its murine orthologue D430044G18Rik.
No orthologues were found in Drosophila melanogaster
and Caenorhabditis elegans. In addition, BLAST searches
on human genomic and translated sequences identiﬁed
another gene, FLJ20356 (GenBank accession number
AK000363), on chromosome 4p16, the putative trans-
lation product of which shares 47% amino acid sequence
identity with the KIAA1985 protein. The FLJ20356 gene
also has conserved orthologues in vertebrates (ﬁg. 5). EST
data suggest that FLJ20356 undergoes differential splic-
ing in a manner similar to that of the KIAA1985 gene.
The Phenotypic Spectrum of CMT4C
The clinical, electrophysiological, and pathological de-
tails of the 18 patients with CMT4C are summarized in
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Figure 3 KIAA1985 mutations in four families with CMT4C. Arrowheads in the electropherograms indicate the disease-causingmutations.
A, Homozygous c.26delG mutation in family M2045, resulting in the R9fsX13 frameshift mutation. The wild-type sequence is shown in the
lower chromatogram. B, Compound heterozygote c.2829TrG and c.2860CrT base substitutions in family M983, resulting in Y943X and
R954X nonsense mutations. C, Compound heterozygote c.1972CrT and c.2860CrT mutations in family H1351, resulting in the R658C
missense and the R954X nonsense mutations. D, Homozygous acceptor splice site IVS5-2ArG mutation in family CMT-189. The wild-type
sequence is shown in the lower chromatogram.
table 1. The age at onset peaked during infancy or the
late 1st and early 2nd decades of life. Early onset of the
disease did not reliably predict a more severe disease or
rapid progression. In some patients, CMT4C progressed
slowly, allowing independent ambulation up to the 5th
decade, whereas others became wheelchair dependent
during their teenage years. One patient (AC70.II.1) had
severe generalized hypotonia and early-onset respiratory
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Figure 4 Expression analysis of KIAA1985. A, Human adult multiple-tissue northern blot. Upper panel, Membrane probed with a
radioactively labeled cDNA fragment corresponding to KIAA1985 exons 15–17. Two strong signals at ∼7.5 kb and ∼4.5 kb are seen in brain
and spinal cord, whereas striated muscle (tongue) gives only faint signals. All other tissues are negative for KIAA1985 expression by northern
blotting. Comparable results were obtained when using a 5′ probe (exons 1–6). Lower panel, Membrane hybridized with radioactively labeled
b-actin cDNA fragment for an internal control. B, Expression analysis by RT-PCR. Upper panel, Ampliﬁcation of a 535-bpKIAA1985 fragment
corresponding to exons 15–17. Lower panel, b2-microglobulin (b-2M)–speciﬁc primers were used in control reactions. KIAA1985 expression
levels in sciatic nerve and spinal cord seem similar. Weak signals are obtained on skeletal muscle mRNA. Genomic DNA was used as a control
to test for speciﬁc ampliﬁcation from cDNA targets. (MWp DNA size standard) C, Expression of different KIAA1985 splice variants in human
brain, spinal cord, and sciatic nerve. RT-PCR with primers positioned in exons 6 and 11 yielded a 694-bp product from transcripts encoding
the longest continuous ORF (arrowheads). The additional bands arise from alternative usage of exons 6s or 8A or retention of intron 10, which
would be predicted to result in truncated forms of the KIAA1985 protein (also see ﬁg. 2). The intact mRNA is the dominant transcript in sciatic
nerve, whereas spinal cord and brain predominantly express alternative splice products.
problems, along with a progressive thoracal scoliosis. Al-
together, prominent scoliosis was observed in 11 of 18
patients with CMT4C. Scoliosis often preceded apparent
pareses, and, in some cases, was the primary reason for
medical referral. Other clinical features displayed by the
patients with CMT4C were likely unrelated to the CMT
(such as diabetes mellitus or nystagmus), represent com-
plications of a neuromuscular disorder (such as respi-
ratory problems arising after a longer course of the dis-
ease), or are not uncommon in peripheral neuropathies
(such as hypoacusis). Motor and sensory NCVs were
reduced, with a mean median motor NCV of 22.6 m/s
(range 4–37 m/s). Nerve biopsy ﬁndings on the light- and
electron-microscopic level displayed a predominantly de-
myelinating neuropathy in all seven subjects for whom a
biopsy specimen was available. The combination of basal
lamina onion bulb formation and extended Schwann cell
processes was apparent in six cases (table 1; ﬁg. 6).
Discussion
In this study, we reﬁned the CMT4C region on chromo-
some 5q32 to 1.7 Mb, within suggestive borders, and
identiﬁed KIAA1985 as the CMT4C gene. In 12 families,
we found eight different protein-truncatingmutations and
three missense mutations affecting evolutionary-con-
served amino acid residues. Affected individuals from
eight families were homozygous or compound hetero-
zygous for truncating mutations. Segregation analyses
of all KIAA1985 mutations were consistent with auto-
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Figure 5 Protein prediction and sequence conservation among the KIAA1985 protein family. A, Full-length protein of 1,288 amino acids,
showing domains as predicted by SMART (bluep SH3 domains; orangep TPR motifs). The sites of mutations detected in this study are indicated.
B, Multiple protein sequence alignment generated with the program ClustalW, using translation from genome assemblies and expressed sequences.
The amino acid numbering is according to the human KIAA1985 protein. Sequence comparison shows that the threeKIAA1985missensemutations
(R529Q, E657K, and R658C) observed in patients with CMT4C affect amino acids that are identical in KIAA1985 and FLJ20356 and their putative
orthologues. (Hsp Homo sapiens; MmpMus musculus; Rnp Rattus norvegicus; Ggp Gallus gallus; Drp Danio rerio; Frp Fugu rubripes.)
Upper panel, Sequence of the ﬁrst TPRmotif. Residues generating the TPR consensus sequence are shown on gray background. Sequence conservation
outside these consensus residues (shown on black background) is believed to correlate with functional specialization of the TPR motif (Blatch and
La¨ssle 1999). Lower panel, Residues from one of the interdomain regions. Conserved amino acids are given on a black background. C, Average
distance tree of KIAA1985 (residues 1000–1100) aligned with homologous sequences. The average distance tree, with percentage identities, was
generated by the program Jalview on the basis of a multiple-sequence alignment generated with the program ClustalW. (Ss p Sus scrofa; Bt p
Bos taurus; Xlp Xenopus laevis.) The following GenBank database entries were used for generating the multiple-sequence alignments:KIAA1985
[accession number AY341075], Bt.KIAA1985 [accession numbers BI680206, BF652287, BU239452, AW656867, and BI976766], Ss.KIAA1985
[accession numbers BF442400, BI186309, BI183894, and BI345340], Mm.KIAA1985/D430044G18Rik [accession number AK052534],
Rn.KIAA1985 [accession numbers BF567582 and XM_225887], Gg.KIAA1985 [accession numbers BU239452 and BU355692], FLJ20356
[accession number AK000363], Mm.FLJ20356 [accession numbers AK028482 and BC024909], Rn.FLJ20356 [accession numbers XM_223527
and XM_223528], Gg.FLJ20356 [accession numbers BU232586, BU471861, and BU474979], Xl.FLJ20356 [accession number BJ062830]).D.
rerio and F. rubripes orthologues were retrieved by translated BLAST searches on unﬁnished genomes, with “human protein sequence” as a
query (Ensembl).
somal recessive inheritance. The absence of mutations
in 10 other families compatible with linkage to CMT4C
is not unexpected, since linkage in small families can be
fortuitous in the setting of genetic heterogeneity. Other-
wise, some of these families may represent CMT4C-af-
fected families with KIAA1985 mutations undetectable
in the present study (e.g., large genomic alterations or
mutations in regulatory sequences). The novel CMT4C
1116 Am. J. Hum. Genet. 73:1106–1119, 2003
Figure 6 Electron micrographs. A, Patient AC70.II.1. A thinly
remyelinated axon is surrounded by several layers of basal membranes
(arrow) that occasionally contain remnants of Schwann cell cytoplasm
(9,000#). B, Patient CMT-133.IV.2. Thin Schwann cell processes (ar-
row) connect isolated unmyelinated axons and show supernumerary
extensions (10,000#).
gene is expressed in neural tissues, including peripheral
nerve, which is consistent with the tissue involved in a
demyelinating peripheral neuropathy.
The clinical, electrophysiological, and pathological
phenotype of patients with CMT4C was described else-
where in detail (Kessali et al. 1997; Gabree¨ls-Festen et
al. 1999). With the identiﬁcation of disease-causingmu-
tations in the CMT4C gene, we have conﬁrmed that
patients with CMT4C can have an early-onset scoliosis,
relatively well-preserved NCVs, and increased basal lam-
ina production and formation of abnormal Schwann cell
processes in their peripheral nerves. However, neuro-
pathic symptoms were not conﬁned to relatively mild
disease. The phenotypic spectrum also included infantile
neuropathy, with early loss of ambulation and respiratory
problems. At present, the limited sample size leaves open
any conclusions regarding genotype-phenotype correla-
tions. We found CMT4C to occur in CMT cohorts of
various ethnic origins. Together with previous studies
(LeGuern et al. 1996; Gabree¨ls-Festen et al. 1999; Guil-
bot et al. 1999), our ﬁndings indicate that CMT4C rep-
resents a comparatively frequent cause of autosomal re-
cessive CMT.
We encountered two aspects that pose challenges to
prediction of the consequences ofKIAA1985mutations.
First, in one Turkish control individual, we have iden-
tiﬁed a heterozygous R529Q mutation, the same muta-
tion as in families CMT-133 and M149. The identical
rare haplotype found on all R529Q chromosomes sup-
ports a common origin of this allele; thus, it is likely that
the recurrence of the R529Q mutation is due to a sam-
pling bias of control DNAs arising from linkage dis-
equilibrium or founder effect. Alternatively, R529Qmay
be a nonpathogenic variant, and an undetected true mu-
tation may reside on the R529Q allele of families CMT-
133 and M149. Finally, with regard to genetic hetero-
geneity in autosomal recessive CMT, linkage data in
small families need to be interpreted with caution. Fami-
lies CMT-133 and M149 may carry a mutation else-
where in the genome and may share a common 5q32
haplotype by chance. Nevertheless, homozygous and
compound heterozygous truncating mutations identi-
ﬁed in this study strongly support the notion that
KIAA1985 is the CMT4C gene.
Second, we discovered a set of KIAA1985-splicing
products that are predicted to have outcomes similar to
those of truncating mutations described for the patients’
DNAs. Although some of these transcripts may repre-
sent messages that are incompletely spliced or that are
not translated into protein, polypeptides lacking major
portions of the protein may exist in normal tissues. We
suggest two potential explanations: First, all mutations
in the CMT4C gene are predicted to alter the sequence
of the longest ORF. This may suggest that a critical
amount of the full-length protein is necessary for re-
taining a normal phenotype. It is notable that the highest
levels of the transcript with the longest ORF were de-
tected in mRNA from peripheral nerve that is primarily
targeted by KIAA1985 mutations. Second, alternative
splicing may serve to maintain a critical functional, spa-
tial, or temporal balance between the different protein
products. Studies on mouse tissues also showed the pres-
ence of alternative transcripts with truncated ORFs, in-
dicating a functional role for this property. A similar
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splicing diversity, with abundant generation of predicted
shorter isoforms, has been described elsewhere in the
regulation of genes controlling cell death (Jiang and Wu
1999; Bingle et al. 2000; Horiuchi et al. 2000). Appear-
ance of Schwann cell death with apoptotic morphology
has been recently noted in the biopsy of a case of infantile
hereditary neuropathy, with evidence of abundant basal
lamina onion bulb formation (Fidzianska et al. 2002).
The transcript with the longest ORF is predicted to
encode a novel protein of unknown function containing
SH3 and TPR motifs, arrayed in a fashion not observed
previously in a protein. SH3 domains—found in a great
variety of membrane-associated, intracellular, and even
extracellular proteins—mediate assembly of protein
complexes via binding to proline-rich peptides (Paw-
son 1995; Stoll et al. 2001; Pfam database [accession
number PF00018]). The TPR motif similarly represents
a protein-protein interactionmodule found inmany func-
tionally diverse proteins (Blatch and La¨ssle 1999; Pfam
database [accession number PF00515]). Common fea-
tures in the interaction partners have not been deﬁned,
but, in some instances, TPR proteins seem to aggregate
to multiprotein complexes. It is conceivable that the
KIAA1985 protein acts as an adapter or docking mole-
cule. Therefore, a search for proteins complexed with
KIAA1985 might be an effective strategy to shed light
on KIAA1985 function and its role in normal and dis-
eased peripheral nerves. BLAST searches on expressed
sequences and genome assemblies revealed conserved
orthologues in various vertebrates from cattle to zebra-
ﬁsh. In addition, we discovered a second human protein,
FLJ20356, with a very similar domain composition. This
suggests that the KIAA1985 and FLJ20356 genes and
their orthologues in other species belong to a multigene
family that encodes putative docking proteins.
In summary, we have identiﬁed the gene responsible
for CMT4C, a recessive CMT neuropathy linked to
chromosome 5q32. The translated protein belongs to a
so-far-unrecognized family of putative adapter proteins.
Functional studies on the CMT4C protein may add to
the knowledge about the pathomechanisms in peripheral
neuropathies. In the meantime, the results of our study
will aid genetic testing and counseling in families with
recessive and sporadic CMTs.
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